Cargando…

Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy

Cardiac hypertrophy is an adaptive enlargement of myocardium in response to pressure overload caused various pathological insults, which is accompanied by alteration of a complex cascade of signaling pathways. During the hypertrophy process, many changes occur at cellular level including gene reprog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yanhan, Xu, Sheng, Liu, Jing, Ponnusamy, Murugavel, Zhao, Yanfang, Zhang, Yanhui, Wang, Qi, Li, Peifeng, Wang, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036733/ https://www.ncbi.nlm.nih.gov/pubmed/29989099 http://dx.doi.org/10.7150/ijbs.26215

Ejemplares similares

The role of K63‐linked polyubiquitination in cardiac hypertrophy
por: Yan, Kaowen, et al.
Publicado: (2018)

MicroRNA as a Therapeutic Target in Cardiac Remodeling
por: Chen, Chao, et al.
Publicado: (2017)

A comprehensive review of circRNA: from purification and identification to disease marker potential
por: Xu, Sheng, et al.
Publicado: (2018)

Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity
por: Wang, Man, et al.
Publicado: (2017)

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy
por: Wang, Zhihua, et al.
Publicado: (2016)

The role of post‐translational modifications in cardiac hypertrophy
por: Yan, Kaowen, et al.
Publicado: (2019)

Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy
por: Jiang, Feng, et al.
Publicado: (2016)

Non‐coding RNAs in cardiac hypertrophy
por: Ottaviani, Lara, et al.
Publicado: (2017)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression
por: Wang, Tao, et al.
Publicado: (2020)

The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
por: Gao, Jinning, et al.
Publicado: (2017)

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination
por: Zhang, Li-jie, et al.
Publicado: (2022)

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017)

Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway
por: Zhang, Mingyu, et al.
Publicado: (2019)

Epigenetic regulation of long non-coding RNAs in gastric cancer
por: Zhou, Zhixia, et al.
Publicado: (2017)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease
por: Zhao, Yanfang, et al.
Publicado: (2019)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
por: Gallicano, G. Ian, et al.
Publicado: (2022)

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy
por: Viereck, Janika, et al.
Publicado: (2020)

A long non-coding RNA protects the heart from pathological hypertrophy
por: Han, Pei, et al.
Publicado: (2014)

Long Non-Coding RNA Epigenetics
por: Kazimierczyk, Marek, et al.
Publicado: (2021)

The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a
por: Zhou, Zhixia, et al.
Publicado: (2018)

Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy
por: Song, Chao, et al.
Publicado: (2016)

A systems biology approach to elucidating epigenetic regulation of cardiac hypertrophy
por: Majumdar, Gipsy, et al.
Publicado: (2013)

A long non-coding RNA LncSync regulates mouse cardiomyocyte homeostasis and cardiac hypertrophy through coordination of miRNA actions
por: Huang, Rujin, et al.
Publicado: (2022)

ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster
por: Migunova, Ekaterina, et al.
Publicado: (2021)

Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: A concise review
por: Aung, Lynn Htet Htet, et al.
Publicado: (2021)

Reactive Oxygen Species Related Noncoding RNAs as Regulators of Cardiovascular Diseases
por: Dong, Yanhan, et al.
Publicado: (2019)

Whole transcriptome microarrays identify long non-coding RNAs associated with cardiac hypertrophy
por: Zhang, Lu, et al.
Publicado: (2015)

PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2
por: Gu, Wei, et al.
Publicado: (2021)

The function of LncRNA-H19 in cardiac hypertrophy
por: Su, Wenhua, et al.
Publicado: (2021)

Critical role of FOXO3a in carcinogenesis
por: Liu, Ying, et al.
Publicado: (2018)

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy
por: Li, Qiaoling, et al.
Publicado: (2016)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Non-coding RNA-related antitumor mechanisms of marine-derived agents
por: Zhou, Zhixia, et al.
Publicado: (2022)

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy
por: Han, Sha-sha, et al.
Publicado: (2015)

New Insights and Current Approaches in Cardiac Hypertrophy Cell Culture, Tissue Engineering Models, and Novel Pathways Involving Non-Coding RNA
por: Kastner, Nina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fh7t06fu7vbu9d7a5d5ojnptts